| Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate CancerAR Gene Aberrations in Circulating … AA Azad, SV Volik, AW Wyatt, A Haegert, S Le Bihan, RH Bell, ... Clinical cancer research 21 (10), 2315-2324, 2015 | 536 | 2015 |
| High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug DevelopmentNext-Generation Models of Prostate Cancer D Lin, AW Wyatt, H Xue, Y Wang, X Dong, A Haegert, R Wu, S Brahmbhatt, ... Cancer research 74 (4), 1272-1283, 2014 | 413 | 2014 |
| Cell-free DNA (cfDNA): clinical significance and utility in cancer shaped by emerging technologies S Volik, M Alcaide, RD Morin, C Collins Molecular Cancer Research 14 (10), 898-908, 2016 | 406 | 2016 |
| Widespread and functional RNA circularization in localized prostate cancer S Chen, V Huang, X Xu, J Livingstone, F Soares, J Jeon, Y Zeng, JT Hua, ... Cell 176 (4), 831-843. e22, 2019 | 385 | 2019 |
| Genomic alterations in cell-free DNA and enzalutamide resistance in castration-resistant prostate cancer AW Wyatt, AA Azad, SV Volik, M Annala, K Beja, B McConeghy, ... JAMA oncology 2 (12), 1598-1606, 2016 | 383 | 2016 |
| Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas G Hodgson, JH Hager, S Volik, S Hariono, M Wernick, D Moore, ... Nature genetics 29 (4), 459-464, 2001 | 371 | 2001 |
| Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients N Lallous, SV Volik, S Awrey, E Leblanc, R Tse, J Murillo, K Singh, ... Genome biology 17 (1), 1-15, 2016 | 252 | 2016 |
| Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors G Zardo, MI Tiirikainen, C Hong, A Misra, BG Feuerstein, S Volik, ... Nature genetics 32 (3), 453-458, 2002 | 233 | 2002 |
| From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer AV Lapuk, C Wu, AW Wyatt, A McPherson, BJ McConeghy, S Brahmbhatt, ... The Journal of pathology 227 (3), 286-297, 2012 | 221 | 2012 |
| The proteogenomic landscape of curable prostate cancer A Sinha, V Huang, J Livingstone, J Wang, NS Fox, N Kurganovs, ... Cancer Cell 35 (3), 414-427. e6, 2019 | 220 | 2019 |
| Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors PL Paris, A Andaya, J Fridlyand, AN Jain, V Weinberg, D Kowbel, ... Human molecular genetics 13 (13), 1303-1313, 2004 | 220 | 2004 |
| End-sequence profiling: sequence-based analysis of aberrant genomes S Volik, S Zhao, K Chin, JH Brebner, DR Herndon, Q Tao, D Kowbel, ... Proceedings of the National Academy of Sciences 100 (13), 7696-7701, 2003 | 204 | 2003 |
| Whole-genome and transcriptome sequencing of prostate cancer identify new genetic alterations driving disease progression S Ren, GH Wei, D Liu, L Wang, Y Hou, S Zhu, L Peng, Q Zhang, Y Cheng, ... European urology 73 (3), 322-339, 2018 | 199 | 2018 |
| Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder CancerctDNA Alterations in Metastatic Bladder Cancer G Vandekerkhove, T Todenhöfer, M Annala, WJ Struss, A Wong, K Beja, ... Clinical Cancer Research 23 (21), 6487-6497, 2017 | 167 | 2017 |
| Evaluation of paired-end sequencing strategies for detection of genome rearrangements in cancer A Bashir, S Volik, C Collins, V Bafna, BJ Raphael PLoS computational biology 4 (4), e1000051, 2008 | 159 | 2008 |
| Comprehensive genome sequence analysis of a breast cancer amplicon C Collins, S Volik, D Kowbel, D Ginzinger, B Ylstra, T Cloutier, T Hawkins, ... Genome research 11 (6), 1034-1042, 2001 | 133 | 2001 |
| BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma R Shrestha, N Nabavi, YY Lin, F Mo, S Anderson, S Volik, HH Adomat, ... Genome medicine 11 (1), 1-12, 2019 | 116 | 2019 |
| Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23–qter and … JE Vivienne Watson, NA Doggett, DG Albertson, A Andaya, A Chinnaiyan, ... Oncogene 23 (19), 3487-3494, 2004 | 109 | 2004 |
| Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer Y Feng, VR Ramnarine, R Bell, S Volik, E Davicioni, VM Hayes, S Ren, ... BMC genomics 20 (1), 1-8, 2019 | 106 | 2019 |
| ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction G Huang, S Krig, D Kowbel, H Xu, B Hyun, S Volik, B Feuerstein, GB Mills, ... Human molecular genetics 14 (21), 3219-3225, 2005 | 103 | 2005 |
